Repository logo
 

Impact of Older Age in Patients Receiving Atezolizumab and Bevacizumab for Hepatocellular Carcinoma

Simple item page
dc.contributor.authorAmar, Suneetha
dc.contributor.authorMuzaffar, Mahvish
dc.contributor.authorNaqash, Abdul Rafeh
dc.contributor.authorVithayathil, Mathew
dc.contributor.authoret al
dc.date.accessioned2023-02-20T13:32:46Z
dc.date.available2023-02-20T13:32:46Z
dc.date.issued2022
dc.identifier.doi10.1111/liv.15405
dc.identifier.issn1478-3223
dc.identifier.urihttp://hdl.handle.net/10342/12345
dc.language.isoen_USen_US
dc.subjectanti-programmed death-liganden_US
dc.subjectanti-vascular endothelial growth factoren_US
dc.subjectimmunotherapyen_US
dc.titleImpact of Older Age in Patients Receiving Atezolizumab and Bevacizumab for Hepatocellular Carcinomaen_US
dc.typeArticleen_US
ecu.journal.issue11en_US
ecu.journal.nameLiver Internationalen_US
ecu.journal.pages2538-2547en_US
ecu.journal.volume42en_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
AmarImpactofOlderAgeinPatientsReceivingAtezolizumabandBevacizumabforHepatocellularCarcinoma.pdf
Size:
1.05 MB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Oncology